Japan greenlights six new drugs; first-ever nod to PD-1 drug Opdivo

TOKYO – Japan's Ministry of Health, Labor and Welfare (MHLW) approved six new drugs, including one biosimilar, underscoring the country's drive to speed up drug approvals. And, in some instances, the approvals were done faster than in the U.S.

To continue reading subscribe now to BioWorld Asia (formerly International)